SpaceX has reportedly filed for the biggest IPO in history

SpaceX has confidentially filed draft IPO paperwork with the SEC seeking to raise roughly $75 billion and targeting a $1.75 trillion IPO valuation, which would eclipse Saudi Aramco's $24 billion record. The confidential filing delays public disclosure of price range and share count while allowing SEC feedback. Proceeds are intended to fund Starship, a lunar base, Mars ambitions and orbital AI data centers.

Analysis

A large public listing of a vertically integrated launch-and-satellite platform will act as a capital magnet that re-routes private-space funding into public markets and into the company’s supplier ecosystem over the next 12–24 months. Expect meaningful revenue step-ups for prime-tier avionics, propulsion and rad‑hard component suppliers as multi-year purchase schedules are accelerated; a conservative working assumption is incremental contract awards in the high‑hundreds-of-millions to low‑single-digit‑billions annually for 2–4 years for a small cohort of vendors.

Second‑order competitive pressure will compress pricing for small‑sat launches and system integration: public scale and price leadership will force commercial small‑launcher margins lower, accelerating consolidation among pure-play small-lift providers and creating margin pressure for satellite operators that cannot vertically integrate. Conversely, aerospace primes with diversified government/defense exposure can monetize higher-margin integration work (space infrastructure, mission systems) even if their pure launch economics worsen — shifting revenue mix but likely preserving FCF in 12–36 months.

Key reversal risks are regulatory and governance: export controls (ITAR/EAR), spectrum disputes, and shareholder/governance challenges tied to multi‑entity ownership could delay capital deployment or force asset carve‑outs; these events are capable of creating 30–50% valuation rerating in 3–12 months. Market sentiment will also be a driver — a risk‑off equity environment or IPO market pullback would materially slow downstream contract awards and capex plans, turning supplier uplift into near‑term headwinds.

Key Decisions for Investors

• Pair trade (12–18 months): Long L3Harris Technologies (LHX) + short Rocket Lab (RKLB). Rationale: LHX to capture multi‑year avionics, payload and rad‑hard component awards; RKLB exposed to pricing pressure in small‑sat launches. Target: LHX +30–50% vs downside -20%; RKLB short target -40% (1:1 position sizing, stop‑loss at 25% adverse move).
• Long Maxar Technologies (MAXR) stock or buy Jan 2028 call spread (bull call) — 12–24 months. Rationale: increased demand for Earth‑and‑space imaging, on‑orbit servicing and lunar/Mars reconnaissance. Risk/Reward: expect +40–80% upside if program awards accelerate; downside ~30–35% on contract slippage or macro slowdown.
• Tactical short (6–12 months): Buy put spread on Rocket/Lifecycle‑exposed small launchers (RKLB or similar) to capitalize on accelerated price competition. Structure: 3–6 month put spread to limit capital and define downside payoff; target 2:1 payoff if small‑launcher revenues miss guidance post‑market re‑pricing.
• Hedge and governance protection (3–12 months): For any newly initiated supplier longs, buy 3–6 month protective puts or collar structures and size net exposure to ≤2% of portfolio. Rationale: limits downside from regulatory/IPO governance shocks which are the largest single‑event reversal risk.